Curis (CRIS) Financials: Revenue & Earnings

CRIS price $0.41 +0.01 +2.61%

Ticker
CRIS
Price
$0.41
Change
+0.01 +2.61%
Market cap ?
$805,350
Beta ?
3.10
Sector
Healthcare
Industry
Biotechnology

Fair value

CRIS fair value $662.13. Price $0.41. Price is 100% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 2.08M. Growth 14.29%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 2.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 1.95M. Net debt -3.44M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare CRIS

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-2.29—1.00M
2026-08-14-4.02-6.95—1.00M
2026-05-12-25.00-5.80—1.69M
2026-03-1924.60-8.721.14M3.25M
2025-11-06-9.80-12.403.18M2.86M
2025-08-05-13.60-39.802.75M2.64M
2025-05-06-25.00-22.802.38M2.65M
2025-03-31-25.00-27.203.35M2.21M
2024-11-14-34.00-36.602.93M2.27M
2024-08-01-40.60-33.402.55M2.06M
2024-05-07-41.00-42.402.09M2.00M
2024-02-08-40.60-42.202.70M3.02M
2023-11-02-42.60-46.602.83M2.54M
2023-08-03-48.00-47.202.20M2.47M
2023-05-04-48.00-2.202.30M2.48M
2023-03-13-48.00-2.802.89M3.19M
2022-11-09-0.56-0.662.83M3.05M
2022-08-04-0.68-0.662.39M2.62M
2022-05-05-0.72-0.642.06M2.40M
2022-02-24-0.60-0.513.13M2.96M
2021-11-09-48.00-52.003.04M2.80M
2021-08-03-48.00-44.002.29M2.29M
2021-05-12-44.00-36.002.19M2.64M
2021-03-16-44.00-28.003.02M2.84M
2020-11-10-44.00-2.602.74M2.57M
2020-08-04-0.68-0.042.36M2.64M
2020-05-12-1.12—2.71M—
2020-03-19-1.04—3.29M—
2019-11-05-0.76—2.86M—
2019-08-06-0.88—2.09M—
2019-05-14-0.76-0.041.77M2.50M
2019-03-26-0.72-0.042.75M3.21M
2018-11-01-0.88-1.242.85M3.75M
2018-08-02-1.04-1.642.36M3.54M
2018-05-03-1.40-1.602.47M3.22M
2018-03-08-1.00-1.803.26M5.87M
2017-11-07-2.20-1.802.44M2.09M
2017-08-03-2.00-1.802.06M1.94M
2017-05-04-2.20-1.802.13M1.67M
2017-03-09-1.60-1.402.36M2.89M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-07-07Rubin MarcBuy6.80K$5.2935.97K
2026-07-07KAITIN KENNETH IBuy6.80K$5.2935.97K
2026-07-07Hohneker JohnBuy6.80K$5.2935.97K
2026-07-07GREENACRE MARTYN DBuy6.80K$5.2935.97K
2026-07-07Borgman Anne ElizabethBuy6.80K$5.2935.97K
2026-07-07Duvall DianthaBuy48.28K$5.29255.43K
2026-07-07Zung Jonathan B.Buy48.28K$5.29255.43K
2026-07-07Dentzer James EBuy110.09K$5.29582.38K
2026-03-31KAITIN KENNETH IBuy10.00K$0.555.49K
2026-03-20Zung Jonathan B.Buy66.67K——
2026-03-20Zung Jonathan B.Sell50——
2026-03-20Hamdy Ahmed MDBuy66.67K——
2026-03-20Hamdy Ahmed MDSell50——
2026-03-20Duvall DianthaBuy66.67K——
2026-03-20Duvall DianthaSell50——
2026-03-20Dentzer James EBuy133.33K——
2026-03-20Dentzer James ESell100——
2026-03-20Rubin MarcBuy26.67K——
2026-03-20Rubin MarcSell20——
2026-03-17Zung Jonathan B.Buy66.67K$0.7550.00K
2026-03-17Zung Jonathan B.Buy66.67K$0.7550.00K
2026-03-17Zung Jonathan B.Buy66.67K$0.7550.00K
2026-03-17Zung Jonathan B.Buy50——
2026-03-17Hamdy Ahmed MDBuy66.67K$0.7550.00K
2026-03-17Hamdy Ahmed MDBuy66.67K$0.7550.00K
2026-03-17Hamdy Ahmed MDBuy66.67K$0.7550.00K
2026-03-17Hamdy Ahmed MDBuy50——
2026-03-17Duvall DianthaBuy66.67K$0.7550.00K
2026-03-17Duvall DianthaBuy66.67K$0.7550.00K
2026-03-17Duvall DianthaBuy66.67K$0.7550.00K
2026-03-17Duvall DianthaBuy50——
2026-03-17Dentzer James EBuy133.33K$0.75100.00K
2026-03-17Dentzer James EBuy133.33K$0.75100.00K
2026-03-17Dentzer James EBuy133.33K$0.75100.00K
2026-03-17Dentzer James EBuy100——
2026-03-17Rubin MarcBuy26.67K$0.7520.00K
2026-03-17Rubin MarcBuy26.67K$0.7520.00K
2026-03-17Rubin MarcBuy26.67K$0.7520.00K
2026-03-17Rubin MarcBuy20——
2025-05-20Dentzer James EBuy360.00K$3.131.13M
2025-05-20Hohneker JohnBuy14.40K$3.1345.07K
2025-05-20GREENACRE MARTYN DBuy14.40K$3.1345.07K
2025-05-20Rubin MarcBuy14.40K$3.1345.07K
2025-05-20Duvall DianthaBuy135.00K$3.13422.55K
2025-05-20Borgman Anne ElizabethBuy14.40K$3.1345.07K
2025-05-20Zung Jonathan B.Buy135.00K$3.13422.55K
2025-05-20KAITIN KENNETH IBuy14.40K$3.1345.07K
2025-05-01Hamdy Ahmed MDBuy200.00K$2.48496.00K
2025-05-01Hamdy Ahmed MDOther0——
2025-01-28Duvall DianthaBuy15.00K$3.1346.95K
2025-01-28Dentzer James EBuy40.00K$3.13125.20K
2025-01-28Zung Jonathan B.Buy15.00K$3.1346.95K
2025-01-28KAITIN KENNETH IBuy1.60K$3.135.01K
2025-01-28Rubin MarcBuy1.60K$3.135.01K
2025-01-28Borgman Anne ElizabethBuy1.60K$3.135.01K
2025-01-28Hohneker JohnBuy1.60K$3.135.01K
2025-01-28GREENACRE MARTYN DBuy1.60K$3.135.01K
2024-05-21Duvall DianthaBuy39.00K$11.62453.18K
2024-05-21Dentzer James EBuy100.00K$11.621.16M
2024-05-21Zung Jonathan B.Buy40.70K$11.62472.93K
2024-05-21KAITIN KENNETH IBuy4.25K$11.6249.38K
2024-05-21Rubin MarcBuy4.25K$11.6249.38K
2024-05-21Borgman Anne ElizabethBuy4.25K$11.6249.38K
2024-05-21Hohneker JohnBuy4.25K$11.6249.38K
2024-05-21GREENACRE MARTYN DBuy4.25K$11.6249.38K
2023-05-01Zung Jonathan B.Buy500.00K$0.83415.00K
2023-05-01Zung Jonathan B.Other0——
2023-01-23KAITIN KENNETH IBuy85.00K——
2023-01-23Hohneker JohnBuy85.00K——
2023-01-23Rubin MarcBuy85.00K——
2023-01-23GREENACRE MARTYN DBuy85.00K——
2023-01-23Borgman Anne ElizabethBuy85.00K——
2023-01-20Duvall DianthaBuy500.00K——
2023-01-20Martell RobertBuy350.00K——
2023-01-20Dentzer James EBuy1.00M——
2022-10-12Borgman Anne ElizabethBuy25.00K——
2022-10-12Borgman Anne ElizabethOther0——
2022-08-05Duvall DianthaSell540.00K$1.12604.80K
2022-01-31Rubin MarcBuy85.00K$3.19271.15K
2022-01-31Kunkel Lori AnneBuy85.00K$3.19271.15K
2022-01-31KAITIN KENNETH IBuy85.00K$3.19271.15K
2022-01-31Hohneker JohnBuy85.00K$3.19271.15K
2022-01-31GREENACRE MARTYN DBuy85.00K$3.19271.15K
2022-01-31Dentzer James ESell3.09K$3.079.50K
2022-01-29Steinkrauss WilliamBuy360.00K$3.091.11M
2022-01-29Martell RobertBuy252.00K$3.09778.68K
2022-01-29Dentzer James EBuy825.00K$3.092.55M
2022-01-27Dentzer James ESell2.41K$3.187.65K
2021-12-02Hohneker JohnBuy25.00K$4.77119.25K
2021-12-02Hohneker JohnOther0——
2021-01-28GREENACRE MARTYN DBuy33.00K$9.14301.62K
2021-01-28Martell RobertBuy126.00K$9.141.15M
2021-01-28Rubin MarcBuy33.00K$9.14301.62K
2021-01-28Steinkrauss WilliamBuy180.00K$9.141.65M
2021-01-28Dentzer James EBuy330.00K$9.143.02M
2021-01-28KAITIN KENNETH IBuy33.00K$9.14301.62K
2021-01-28Kunkel Lori AnneBuy33.00K$9.14301.62K
2021-01-26Dentzer James ESell3.09K$10.5932.76K
2021-01-25Dentzer James ESell2.28K$10.9625.02K
2020-03-02KAITIN KENNETH IBuy180.00K$1.26226.80K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 35, holders -7 vs prior quarter. Ownership 31.39%.

HolderSharesChangeChange %Value
BLEICHROEDER LP3.80M00.00%1.99M
STONEPINE CAPITAL MANAGEMENT, LLC3.31M-414.22K-11.12%1.73M
SPHERA FUNDS MANAGEMENT LTD.99.00K-1.90M-95.04%1.03M
NANTAHALA CAPITAL MANAGEMENT, LLC1.98M-21.12K-1.06%1.03M
CABLE CAR CAPITAL, LP1.33M00.00%696.13K
CM MANAGEMENT, LLC550.00K400.00K+266.67%287.15K
MORGAN STANLEY504.29K250.05K+98.35%263.29K
VANGUARD CAPITAL MANAGEMENT LLC343.84K-30.48K-8.14%179.49K
GEODE CAPITAL MANAGEMENT, LLC293.10K124.77K+74.12%153.04K
M28 CAPITAL MANAGEMENT LP284.89K00.00%148.74K
FLPUTNAM INVESTMENT MANAGEMENT CO245.75K245.75KNew128.31K
RENAISSANCE TECHNOLOGIES LLC141.97K-224.77K-61.29%74.12K
XTX TOPCO LTD108.16K108.16KNew56.47K
NORTHERN TRUST CORP95.87K85.38K+813.74%50.05K
VANGUARD FIDUCIARY TRUST CO61.66K00.00%32.19K
BLACKROCK, INC.53.33K-150-0.28%27.85K
FOCUSED WEALTH MANAGEMENT, INC50.05K-59.70K-54.40%26.13K
GSA CAPITAL PARTNERS LLP22.76K22.76KNew12.00K
STATE STREET CORP21.05K00.00%10.99K
FRANKLIN STREET ADVISORS INC /NC20.00K00.00%10.44K
LPL FINANCIAL LLC14.98K-9.00K-37.54%7.82K
MAVERICK CAPITAL LTD49.55K00.00%6.19K
DAUNTLESS INVESTMENT GROUP, LLC10.00K-648.72K-98.48%5.22K
BARCLAYS PLC6.97K6.97KNew3.64K
STEWARD PARTNERS INVESTMENT ADVISORY, LLC2.60K00.00%1.36K

Earnings and financials

Curis, Inc. (CRIS) trades at $0.41, with a market cap of $805,350 and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Curis (CRIS) Financials: Revenue & Earnings

CRIS$0.41+0.01 +2.61%

$805,350

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History